Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YF476 in Type I Gastric Carcinoids
NCT01339169Phase 2Completed
- Sponsor
- Trio Medicines Ltd
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of netazepide, sponsored by Trio Medicines Ltd. Started Jan 2011; status: completed.
02
Drugs
netazepide
Beyond the preview
Go deeper on NCT01339169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339169.